Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35471
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMcDonald, Christine F-
dc.contributor.authorSerginson, John-
dc.contributor.authorAlShareef, Saad-
dc.contributor.authorBuchan, Catherine-
dc.contributor.authorDavies, Huw-
dc.contributor.authorMiller, Belinda R-
dc.contributor.authorMunsif, Maitri-
dc.contributor.authorSmallwood, Natasha-
dc.contributor.authorTroy, Lauren-
dc.contributor.authorKhor, Yet Hong-
dc.date2024-
dc.date.accessioned2024-09-12T00:46:51Z-
dc.date.available2024-09-12T00:46:51Z-
dc.date.issued2024-09-
dc.identifier.citationRespirology (Carlton, Vic.) 2024-09; 29(9)en_US
dc.identifier.issn1440-1843-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/35471-
dc.description.abstractThis Thoracic Society of Australia and New Zealand Guideline on the provision of home oxygen therapy in adults updates a previous Guideline from 2015. The Guideline is based upon a systematic review and meta-analysis of literature to September 2022 and the strength of recommendations is based on GRADE methodology. Long-term oxygen therapy (LTOT) is recommended for its mortality benefit for patients with COPD and other chronic respiratory diseases who have consistent evidence of significant hypoxaemia at rest (PaO2 ≤ 55 mm Hg or PaO2 ≤59 mm Hg in the presence of hypoxaemic sequalae) while in a stable state. Evidence does not support the use of LTOT for patients with COPD who have moderate hypoxaemia or isolated nocturnal hypoxaemia. In the absence of hypoxaemia, there is no evidence that oxygen provides greater palliation of breathlessness than air. Evidence does not support the use of supplemental oxygen therapy during pulmonary rehabilitation in those with COPD and exertional desaturation but normal resting arterial blood gases. Both positive and negative effects of LTOT have been described, including on quality of life. Education about how and when to use oxygen therapy in order to maximize its benefits, including the use of different delivery devices, expectations and limitations of therapy and information about hazards and risks associated with its use are key when embarking upon this treatment.en_US
dc.language.isoeng-
dc.subjectclinical respiratory medicineen_US
dc.subjecthypoxaemiaen_US
dc.subjectlong‐term oxygen therapyen_US
dc.subjectoxygen guidelineen_US
dc.subjectoxygen therapyen_US
dc.titleThoracic Society of Australia and New Zealand clinical practice guideline on adult home oxygen therapy.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleRespirology (Carlton, Vic.)en_US
dc.identifier.affiliationRespiratory and Sleep Medicineen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Sunshine Coast Health, Birtinya, Queensland, Australia.;School of Nursing, Midwifery & Social Work, University of Queensland, St Lucia, Queensland, Australia.en_US
dc.identifier.affiliationDepartment of Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.en_US
dc.identifier.affiliationInstitute for Breathing and Sleepen_US
dc.identifier.affiliationRespiratory and Sleep Services, Flinders Medical Centre, Southern Adelaide Local Health Network, South Australia, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.;Central Clinical School, Monash University, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.;Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.;Institute for Academic Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.en_US
dc.identifier.doi10.1111/resp.14793en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-6481-3391en_US
dc.identifier.orcid0000-0002-3403-3586en_US
dc.identifier.orcid0000-0002-7426-336Xen_US
dc.identifier.orcid0000-0002-5434-9342en_US
dc.identifier.pubmedid39009413-
dc.description.volume29-
dc.description.issue9-
dc.description.startpage765-
dc.description.endpage784-
dc.subject.meshtermssecondaryOxygen Inhalation Therapy/methods-
dc.subject.meshtermssecondaryOxygen Inhalation Therapy/standards-
dc.subject.meshtermssecondaryHome Care Services/standards-
dc.subject.meshtermssecondaryPulmonary Disease, Chronic Obstructive/therapy-
dc.subject.meshtermssecondaryHypoxia/therapy-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptRespiratory and Sleep Medicine-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Nov 1, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.